263 related articles for article (PubMed ID: 9215744)
21. lacZ transgenic rats tolerant for beta-galactosidase: recipients for gene transfer studies using lacZ as a reporter gene.
Ménoret S; Aubert D; Tesson L; Braudeau C; Pichard V; Ferry N; Anegon I
Hum Gene Ther; 2002 Jul; 13(11):1383-90. PubMed ID: 12162820
[TBL] [Abstract][Full Text] [Related]
22. A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector.
Zhou H; Zhao T; Pastore L; Nageh M; Zheng W; Rao XM; Beaudet AL
Mol Ther; 2001 Apr; 3(4):613-22. PubMed ID: 11319924
[TBL] [Abstract][Full Text] [Related]
23. Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: role of the immune response.
Gilgenkrantz H; Duboc D; Juillard V; Couton D; Pavirani A; Guillet JG; Briand P; Kahn A
Hum Gene Ther; 1995 Oct; 6(10):1265-74. PubMed ID: 8590730
[TBL] [Abstract][Full Text] [Related]
24. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity.
Schiedner G; Morral N; Parks RJ; Wu Y; Koopmans SC; Langston C; Graham FL; Beaudet AL; Kochanek S
Nat Genet; 1998 Feb; 18(2):180-3. PubMed ID: 9462752
[TBL] [Abstract][Full Text] [Related]
25. Selective depletion or blockade of Kupffer cells leads to enhanced and prolonged hepatic transgene expression using high-capacity adenoviral vectors.
Schiedner G; Hertel S; Johnston M; Dries V; van Rooijen N; Kochanek S
Mol Ther; 2003 Jan; 7(1):35-43. PubMed ID: 12573616
[TBL] [Abstract][Full Text] [Related]
26. Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung.
Kaplan JM; Armentano D; Sparer TE; Wynn SG; Peterson PA; Wadsworth SC; Couture KK; Pennington SE; St George JA; Gooding LR; Smith AE
Hum Gene Ther; 1997 Jan; 8(1):45-56. PubMed ID: 8989994
[TBL] [Abstract][Full Text] [Related]
27. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.
Juillard V; Villefroy P; Godfrin D; Pavirani A; Venet A; Guillet JG
Eur J Immunol; 1995 Dec; 25(12):3467-73. PubMed ID: 8566039
[TBL] [Abstract][Full Text] [Related]
28. A new vector system with inducible E2a cell line for production of higher titer and safer adenoviral vectors.
Zhou H; Beaudet AL
Virology; 2000 Sep; 275(2):348-57. PubMed ID: 10998335
[TBL] [Abstract][Full Text] [Related]
29. Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen.
Qin L; Ding Y; Pahud DR; Robson ND; Shaked A; Bromberg JS
Hum Gene Ther; 1997 Jul; 8(11):1365-74. PubMed ID: 9295131
[TBL] [Abstract][Full Text] [Related]
30. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons.
Morral N; O'Neal W; Rice K; Leland M; Kaplan J; Piedra PA; Zhou H; Parks RJ; Velji R; Aguilar-Córdova E; Wadsworth S; Graham FL; Kochanek S; Carey KD; Beaudet AL
Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12816-21. PubMed ID: 10536005
[TBL] [Abstract][Full Text] [Related]
31. Variables affecting in vivo performance of high-capacity adenovirus vectors.
Schiedner G; Hertel S; Johnston M; Biermann V; Dries V; Kochanek S
J Virol; 2002 Feb; 76(4):1600-9. PubMed ID: 11799154
[TBL] [Abstract][Full Text] [Related]
32. Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung.
Jooss K; Yang Y; Wilson JM
Hum Gene Ther; 1996 Aug; 7(13):1555-66. PubMed ID: 8864756
[TBL] [Abstract][Full Text] [Related]
33. Selective gene transfer into the liver of non-human primates with E1-deleted, E2A-defective, or E1-E4 deleted recombinant adenoviruses.
Raper SE; Haskal ZJ; Ye X; Pugh C; Furth EE; Gao GP; Wilson JM
Hum Gene Ther; 1998 Mar; 9(5):671-9. PubMed ID: 9551615
[TBL] [Abstract][Full Text] [Related]
34. Germline incorporation of a replication-defective adenoviral vector in mice does not alter immune responses to adenoviral vectors.
Camargo FD; Huey-Louie DA; Finn AV; Sassani AB; Cozen AE; Moriwaki H; Schneider DB; Agah R; Dichek DA
Mol Ther; 2000 Nov; 2(5):496-504. PubMed ID: 11082323
[TBL] [Abstract][Full Text] [Related]
35. Heterologous expression of adenovirus E3-gp19K in an E1a-deleted adenovirus vector inhibits MHC I expression in vitro, but does not prolong transgene expression in vivo.
Schowalter DB; Tubb JC; Liu M; Wilson CB; Kay MA
Gene Ther; 1997 Apr; 4(4):351-60. PubMed ID: 9176522
[TBL] [Abstract][Full Text] [Related]
36. Modulation of the inflammatory properties and hepatotoxicity of recombinant adenovirus vectors by the viral E4 gene products.
Christ M; Louis B; Stoeckel F; Dieterle A; Grave L; Dreyer D; Kintz J; Ali Hadji D; Lusky M; Mehtali M
Hum Gene Ther; 2000 Feb; 11(3):415-27. PubMed ID: 10697116
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted.
Lusky M; Christ M; Rittner K; Dieterle A; Dreyer D; Mourot B; Schultz H; Stoeckel F; Pavirani A; Mehtali M
J Virol; 1998 Mar; 72(3):2022-32. PubMed ID: 9499056
[TBL] [Abstract][Full Text] [Related]
38. Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice.
Yoon SK; Armentano D; Wands JR; Mohr L
Cancer Gene Ther; 2001 Aug; 8(8):573-9. PubMed ID: 11571535
[TBL] [Abstract][Full Text] [Related]
39. Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3.
Gorziglia MI; Lapcevich C; Roy S; Kang Q; Kadan M; Wu V; Pechan P; Kaleko M
J Virol; 1999 Jul; 73(7):6048-55. PubMed ID: 10364357
[TBL] [Abstract][Full Text] [Related]
40. Adenovirus-mediated hepatic gene transfer in mice: comparison of intravascular and biliary administration.
Peeters MJ; Patijn GA; Lieber A; Meuse L; Kay MA
Hum Gene Ther; 1996 Sep; 7(14):1693-9. PubMed ID: 8886840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
